UBS Group AG - EPIRUS BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 37 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$4,000
-20.0%
8,783
+409.2%
0.00%–
Q4 2015$5,000–1,725
+21462.5%
0.00%–
Q3 2015$0
-100.0%
8
-99.1%
0.00%–
Q2 2015$5,000–940
+11650.0%
0.00%–
Q1 2015$0
-100.0%
8
-99.6%
0.00%–
Q4 2014$12,000–2,099–0.00%–
 Download
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders